News
-
-
PRESS RELEASE
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
ONWARD Medical reports successful Q3 2025 with 40 ARC-EX Systems sold, regulatory milestones achieved, science & tech advancements highlighted, and record revenue surpassing EUR 1 million -
-
-
PRESS RELEASE
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
ONWARD Medical N.V. announces groundbreaking advancements in blood pressure regulation after Spinal Cord Injury with ARC-IM Therapy, supported by clinical evidence in Nature and Nature Medicine -
-
-
PRESS RELEASE
ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025
ONWARD Medical showcases commercial progress and advances pipeline in the first half of 2025, meeting sales targets, achieving regulatory milestones, and demonstrating science & technology leadership -
-